Osteoporosis is a progressive bone disease that is characterized by a decrease in bone mass and deterioration in microarchitecture. This study investigates the feasibility of characterizing bone microstructure by analyzing the frequency spectrum of the photoacoustic signals from the bone. Modeling and numerical simulation of photoacoustic signals and their frequency-domain analysis were performed on trabecular bones with different mineral densities. The resulting quasilinear photoacoustic spectra were fit by linear regression, from which spectral parameter slope can be quantified. The modeling demonstrates that, at an optical wavelength of 685 nm, bone specimens with lower mineral densities have higher slope. Preliminary experiment on osteoporosis rat tibia bones with different mineral contents has also been conducted. The finding from the experiment has a good agreement with the modeling, both demonstrating that the frequency-domain analysis of photoacoustic signals can provide objective assessment of bone microstructure and deterioration. Considering that photoacoustic measurement is non-ionizing, non-invasive, and has sufficient penetration in both calcified and noncalcified tissues, this new technology holds unique potential for clinical translation.
INTRODUCTION
In the last decade, osteoporosis has been widely recognized as a major health issue. It is a progressive bone disease that is characterized by a decrease in bone mass and density which can lead to an increased risk of fracture [1] . In osteoporosis, the bone mineral density (BMD) is reduced, bone microarchitecture (BMA) deteriorates, and the amount and variety of proteins in bone are altered. Nowadays, most of the clinically available diagnostic methods are based on the use of either X-ray or ultrasound (US) [2] . The BMD provided by dual X-ray absorptiometry (DXA) is considered as the "gold standard" for osteoporosis diagnosis. But this parameter can only able to explain 60-80% of the variability in bone strength [3] . It has been demonstrated that other mechanical aspects including microarchitecture, bone geometry and elastic properties are also important in determining the fracture risk of bone [4, 5] . These factors, however, cannot be tested by DXA. Quantitative computed tomography (QCT), with the capability to present three-dimensional (3D) features, can evaluate trabecular thickness, spacing, and bone volume fraction. Although QCT has important advantages over DXA, the radiation dose induced by QCT is significantly higher (1 mSv vs. 10 μSv), which limits the applicability of QCT not only for screening but also for diagnosis. Non-ionizing and non-invasive quantitative ultrasound (QUS) technologies provide a practical and low-cost surrogate for DXA and QCT. QUS assessment of bone structure and strength is mainly performed on the transmission mode and based on the measurement of two key parameters including speed of sound (SOS) and broadband ultrasonic attenuation (BUA). These parameters, calculated as the mean values of all bone tissue including both cortical and trabecular bone along the ultrasound transmission path, are strongly correlated with BMD but less reflecting the information of bone microstructure [6] [7] [8] .
Photoacoustic (PA), an emerging hybrid technology involving both ultrasound and light, has excellent sensitivity to the chemical and physiological information in biological samples by probing the intrinsic optical absorption contrast in tissue. Benefited from its ultrasonic spatial resolution, PA imaging is able to accurately map the 3D distribution of functional information in optically scattering tissue with an imaging depth up to several centimeters. Recently studies from our group and others have also demonstrated that the frequency domain power distribution of radio-frequency (RF) PA signals contains information of histological microstructures in biological samples [9] [10] [11] [12] [13] . To objectively evaluate microstructures for potential tissue characterization, a new technique named photoacoustic spectral analysis (PASA), extended from the framework of ultrasound spectral analysis, was established and adapted to the assessment of cancerous tumors and liver conditions [13, 14] . These studies suggest that PASA may offer fundamental advantages for addressing a number of practical problems faced by conventional PA imaging. PASA separates the effects from system components and tissue properties on image features, and delivers system-independent quantitative results. Moreover, performing linear fitting of the power spectrum provides a cogent means of addressing the stochastic nature of tissue microstructures, and can lead to quantitative and repeatable measurements.
In this study, the PASA technique has been adapted to characterization of the microstructures of trabecular bone. Both theoretical modeling and experimental measurements on well-established rat models of bone loss and preservation were conducted. The power spectrum of the RF PA signals from each bone specimen was analyzed, and the spectral parameters, including midband fit, intercept, and slope, in the trabecular part of the bone can be quantified. According to our previous studies [9-11, 13, 14] , among the three PA spectral parameters, midband fit and intercept are more sensitive to the overall optical absorption in the target tissue reflecting the concentrations of optically absorbing chemical components. The quantification of midband fit and intercept is also heavily relying on the accurate measurement of the local light fluence in the tissue which is usually very challenging when performed in vivo. Slope is more sensitive to the tissue heterogeneity reflecting the histological microstructures and spatial distributions of the optical absorbing chemical components, e.g. the structure of trabeculae in the bone. Compared to the other two parameters, slope is less susceptible to the light fluence and, hence, is more reliable for quantitative imaging and objective tissue characterization. Therefore, in this study, the PA spectral parameter slope of each bone specimen was quantified and correlated with the BMD of the bone.
MODELING
The past studies have demonstrated that the frequency domain power distribution of RF PA signals from a target tissue contains the information of tissue histological microstructures. To evaluate the feasibility of PASA in evaluating the microstructures in trabecular bone for potential bone characterization, we first conducted simulations on bone models. PA signal generated and penetrated through trabecular bone were simulated using k-wave toolbox of Matlab developed by B. T. Cox group [15] . K-wave (wave number domain) method which could take into account the heterogeneous media is / m kg , respectively, for water and trabeculae. In each model, the PA source was simulated following a 2D Gaussian distribution. To calculate the mean and the standard deviation, PA signals were measured as 50 different positions evenly distributed around each bone sample. The results from both of the two models demonstrate that, as the BMD increases, the high frequency components of the PA power spectrum decrease. This meets our expectation, since when BMD increases the average size of trabeculae increases. As the trabeculae is the dominant PA source in trabecular bone, the larger trabeculae produces weaker PA signal in the high frequency range. By performing a linear fit of each power spectrum, the spectral parameter slope can be quantified. As shown in both Fig. 1 and Fig. 2 , the bone samples with lower BMD have higher slope.
EXPERIMENT

Experimental setup
As shown in Fig. 3(A) , an OPO system (Vibrant B, Opotek) pumped by an Nd: YAG laser (Brilliant B, Bigsky) was used to provide laser pulses with a repetition rate of 10Hz and a pulse width of 5.5 ns. The laser beam with 2 mm in diameter illuminating the bone generates PA signals which were received by a 20 MHz focused transducer (V317, Panametrics). The bone sample and the transducer were immersed in a water bath for acoustic coupling. The PA signals from the bone specimen were recorded by a digital oscilloscope (TDS 540B, Tektronics). An example A-line PA signal from a rat femur is shown in Fig. 3(B) . In this study, we tried to avoid the strong signal from the cortical bone and focus on the trabecular part of the bone only. To achieve this, the direction of light illumination and the direction of PA signal detection were arranged with an angle between them larger than 90 degree. In this case, the huge PA signal from the cortical bone at the light illuminated side will arrive the transducer later than the PA signal from the trabecular part. As marked by the ROI in Fig. 3(B) , the trabecular signal can be differentiated from others based on the different time of flight. The calibration measurement used for PA spectral analysis was performed on a hair fiber with a diameter of 70 μm, as shown in Fig. 3 (C) . The PA signal from the hair fiber was generated using the same light illumination geometry with the same incident energy density as those for the measurement on bone specimens. The hair fiber was placed at the focal point of the transducer. With a small size comparable to the wavelength at the center frequency of the transducer, the hair fiber illuminated by the laser beam formed a point source with a broadband PA signal, as shown in Fig. 3(D) . To account for the system response, the measurement from each bone was calibrated by dividing the PA power spectrum from the bone by the PA power spectrum of the hair fiber.
Animal model
PA measurement was performed on well-established rat models of bone loss and preservation. 12 femur bones in total from three groups of rats subject to 1) ovariectomy-induced bone loss (OVX, N=4), 2) preservation of bone mass with Zoledronic Acid (OVX+ZOL, N=4), and 3) normal controls (Sham, N=4) provide specimens with low, high, and normal BMD, respectively. The FDA requires the use of the ovariectomized rat model for evaluation of agents used to treat or prevent postmenopausal osteoporosis, and the model has been validated based on the early bone turnover that produces bone loss following estrogen withdrawal. PA measurement was performed ex vivo on the femur head underwent 3 months of bone loss or preservation.
Experimental results
Linear regression of the calibrated PA power spectrum of each bone specimen was performed over the usable bandwidth of 2.8~31.5 MHz of the system. The usable bandwidth is defined as the range of frequencies within -30 dB off the peak of the PA power spectrum of the hair fiber. The Fig. 4 (A) shows the calibrated PA power spectral density (PSD) with the ROI best-fit line by using least-square method. The linear fit enables the extraction of the spectral parameters including the slope that will be quantified and analyzed. Fig. 4 (B) shows the calibrated and averaged PA power spectrum for each of the three groups of bone specimens. In comparison with the sham control (normal), the power spectrum from the OVX bones containing less and thinner trabeculae has stronger high frequency components; while the OVX+ZOL bones containing higher amount and larger size of trabeculae shows weaker high frequency components. The quantified slope for the three groups of bone specimens are compared in Figs. 4(C), demonstrating that, at 685 nm, the osteoporosis bones (OVX) have larger slope than the bones from the other two groups with higher BMD. The finding from the experiment on the rat models of bone loss and preservation shows a good agreement with that from modeling.
CONCLUSION
The results from this preliminary study suggest the feasibility of novel PASA technique in assessment of bone health. The microstructures of trabeculae, an important factor determining the bone strength can be correlated with the spectral parameter slope of the power spectrum of the RF PA signals from the bone. Considering the unique advantages of PA measurement, including high sensitivity, non-ionizing and non-invasive feature, and sufficient penetration in both calcified and non-calcified tissues, this new PASA technique holds a potential for translation into clinical settings. In the future, PASA can be either used alone or combined with existing QUS technologies for bone. Considering that both PASA and QUS involve the detection of ultrasonic signals, an integrated dual-modality system facilitating simultaneous PA and US measurements of a target tissue would be ideal. Unlike QUS, the ultrasonic signal in PASA is not produced by the transducer but instead by the laser light illumination in the bone. The frequency components of the initial pressure waves in the trabecular bone are entirely relying on its histological microstructures. Therefore, it is reasonable to expect that the PA signals from the bone may carry richer and more direct information of bone structures. Before being received by the transducer, the PA signal penetration in the trabecular and cortical parts of the bone would be affected by the acoustic properties of the bone, e.g. ultrasonic attenuation. In bones with higher BMD (e.g. OVX+ZOL), the ultrasound attenuation is stronger, especially at high frequency, which also affects the shape of the power spectrum of the received PA signal and leads to smaller slope. Therefore, the quantified spectral parameter slope is a combination of not only tissue microstructures but also its ultrasonic properties. In order to separate these two aspects, tissue ultrasonic properties which could be quantified by QUS may be introduced in the signal processing for PASA.
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